Skip to content
MedsAcross

Medicine

Sotalol 240 mg tablet

Sotalol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Sotalol 240 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Sotalol
Brand
Sold under the generic name
Strength
240 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 50 tablets and 4 more
Manufacturers
AiPing PharmaceuticalApotexBryant Ranch PrepackNorthwind HealthOxford PharmaceuticalsPD-Rx PharmaceuticalsTeva Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C07AA07 Sotalol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 May 2000
Identifiers
RxCUI 904589, 1923422, 1923424 +4DailyMed set ID 8e2772cb-7dea-42d1-ba31-d479ba7cb09a, 56326224-fc80-4b89-8ba3-70cb873173b4, fe82c866-03d4-e07b-e053-6394a90a8b1e +4NDC 0093-1063, 11788-054, 51655-450 +4Application ANDA075429, ANDA075500, ANDA076140 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle11788-054-01AiPing Pharmaceutical1 November 2025
100 tablet in 1 bottle60505-0082-0Apotex1 February 2003
100 tablet in 1 bottle69584-844-10Oxford Pharmaceuticals24 July 2020
100 tablet in 1 bottle0093-1063-01Teva Pharmaceuticals5 May 2000
100 tablet in 1 bottle72162-2586-1Bryant Ranch Prepack24 November 2025
50 tablet in 1 bottle, plastic51655-450-15Northwind Health14 June 2023
100 tablet in 1 bottle, plastic72789-136-01PD-Rx Pharmaceuticals6 November 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 October 1992Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Sotalol

Clinical summary

Sotalol is an antiarrhythmic indicated for the treatment of life-threatening ventricular arrhythmias the maintenance of normal sinus rhythm in patients with atrial fibrillation or flutter (AFIB/AFL), among other approved uses. MedsAcross supplies Sotalol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sotalol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Sotalol 240 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.